CardioNet, Inc. (BEAT)

[BlazingStocks]

It's trading just over 25% of its 10-day average volume as we head into the close... but UP almost 5%.

$BEAT

[ProfitScout]

These new studies demonstrating increased risk of heart attack or other dangerous cardiac events underscore the importance of new advancements in cardiac monitoring such as the BEAT technology provides. With everyone working harder and longer today than ever before, stress factors including insomnia will only become more prevalent. The BEAT technology can play increasingly important role in keeping people with existing heart conditions safer and living better lives.

[BlazingStocks]

The LIVMOR acquisition Extends HeartBeam’s Reach with FDA-cleared Halo+™ Atrial Fibrillation Detection System and Physician-prescribed Integrated Patient Care Platform

$BEAT

[BlazingStocks]

This was a very interesting article...


$BEAT

[jedijazz]

$BEAT Occupational physical activity raises heart disease risk in men, but not women.
https://t.co/qK2BmYjELn

Occupational physical activity raises heart disease risk in men, but not women https://t.co/qK2BmYjELn

— HeartBeam, Inc. (@HeartBeamInc) March 20, 2023

[BlazingStocks]

This is a very interesting technology and sounds like a great product to help reduce heart attacks...

$BEAT

[BlazingStocks]

This was a great acquisition...

Acquired Assets from LIVMOR, Extending Reach in Remote Monitoring and Detection with an Existing Cutting Edge FDA-Cleared Product, Halo+™ Atrial Fibrillation Detection System

$BEAT

[jedijazz]

$BEAT Study: Insomnia Linked to Increased Risk of Heart Attack, Especially for Women
https://health.com/insomnia-heart-attack-7368320?utm_source=twitter&utm_medium=social&utm_campaign=shareurlbuttons via
@health_com_

Study: Insomnia Linked to Increased Risk of Heart Attack, Especially for Women https://t.co/yb1KyomUip via @health_com_

— HeartBeam, Inc. (@HeartBeamInc) March 23, 2023

[jedijazz]

HeartBeam, Inc. (NASDAQ: BEAT) is a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere. By applying a suite of proprietary algorithms to simplify vector electrocardiography (VECG), the HeartBeam platform enables patients and their clinicians to determine if symptoms are due to a heart attack, quickly and easily, so care can be expedited, if required. HeartBeam has two patented products in development. HeartBeam AIMI™ is software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to more accurately identify a heart attack. HeartBeam AIMIGo™ is the first and only credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote heart attack detection. HeartBeam AIMI and AIMIGo have not yet been cleared by the US Food and Drug Administration (FDA) for marketing in the USA or other geographies. For more information, visit HeartBeam.com.

[jedijazz]

$BEAT Acquired Assets from LIVMOR, Extending Reach in Remote Monitoring and Detection with an Existing Cutting Edge FDA-Cleared Product, Halo+™ Atrial Fibrillation Detection System; HeartBeam Reports Fourth Quarter and Full Year 2022 Financial Results https://finance.yahoo.com/news/heartbeam-reports-fourth-quarter-full-200100156.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr

[BlazingStocks]

About HeartBeam, Inc.

HeartBeam, Inc. (NASDAQ: $BEAT) is a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere. By applying a suite of proprietary algorithms to simplify vector electrocardiography (VECG), the HeartBeam platform enables patients and their clinicians to determine if symptoms are due to a heart attack, quickly and easily, so care can be expedited, if required. HeartBeam has two patented products in development. HeartBeam AIMI™ is software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to more accurately identify a heart attack. HeartBeam AIMIGo™ is the first and only credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote heart attack detection. HeartBeam AIMI and AIMIGo have not yet been cleared by the US Food and Drug Administration (FDA) for marketing in the USA or other geographies. For more information, visit HeartBeam.com.

[BlazingStocks]

$BEAT News March 20, 2023

HeartBeam, Inc. (NASDAQ:BEAT) Q4 2022 Earnings Call Transcript
https://finance.yahoo.com/news/heartbeam-inc-nasdaq-beat-q4-070607632.html

[BlazingStocks]

Very significant acquisition...

Under the terms of the acquisition agreement, HeartBeam purchased LIVMOR’s intellectual property for an undisclosed amount, including 3 issued United States patents, LIVMOR technology, including the Halo AF Detection System, LIVMORs business contracts and relationships as well as all Samsung watch and tablet inventory. Additionally, HeartBeam hired LIVMOR’s key technical employees.

$BEAT

[BlazingStocks]

Some pretty significant accomplishments and developments

Acquired Assets from LIVMOR, Extending Reach in Remote Monitoring and Detection with an Existing Cutting Edge FDA-Cleared Product, Halo+™ Atrial Fibrillation Detection System

Partnered with Evolve Manufacturing to Build HeartBeam AIMIGo 12-Lead 3D Vector Electrocardiogram Device

Received European Patent for HeartBeam AIMIGo Technology

Initial FDA Submission of HeartBeam AIMIGo™, the Telehealth Solution, Projected for Q2 2023

$BEAT

[jedijazz]

$BEAT $2.40 +5.73% HeartBeam, Inc. (NASDAQ:BEAT) Q4 2022 Earnings Call Transcript March 17, 2023
https://finance.yahoo.com/news/heartbeam-inc-nasdaq-beat-q4-070607632.html

[jedijazz]

HeartBeam Announces Acquisition of LIVMOR Assets; Extends HeartBeam’s Reach with FDA-cleared Halo+™ Atrial Fibrillation Detection System and Physician-prescribed Integrated Patient Care Platform https://finance.yahoo.com/news/heartbeam-announces-acquisition-livmor-assets-123100675.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance $BEAT

[ProfitScout]

HeartBeam Reports Fourth Quarter and Full Year 2022 Financial Results
News Link:
https://www.businesswire.com/news/home/20230316005691/en/HeartBeam-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-Results

[starkd748]

5.15 top came back later

[starkd748]

Finnair bust 6$

[starkd748]

Got interesting again

[starkd748]

Good job....Artificial mini pump on low volume

[tw0122]

Flipped out at 4.04 from 3.58 entry

[starkd748]

Yes but rsi frothy

[tw0122]

Chart looks like running a few more days

https://stockcharts.com/h-sc/ui?s=beat

[starkd748]

Weeeee

[1hot toddy]

27000 SHARE BUY. LITTLE MONSTER HERE BOYS $$$$$$$$$$$$$$$$$

[starkd748]

3.30s yesssss

[TopPick]

Slow grind down

[starkd748]

Yess come on down

[starkd748]

Looks like head n shoulders coming and then 3s and maybe 2s

[TopPick]

That would be nice

[starkd748]

Waiting for 3.30s and 2.42s

[TopPick]

It’s all good Ill let this stew and buy some at the lows

[starkd748]

Nov 13th is the vote for it lol read the filings it's on ihub

[TopPick]

Oh shit they didnt amend that? This is going to get crushed

[starkd748]

Headed to 3.30 they want to increase authorize shares to 100milly

[Wi]

Close green today. $$$

[starkd748]

And she is officially toast fell past 4.50s get ready for 3s or maybe 2s

[starkd748]

Weeeee collapse come on 3s

[starkd748]

Fell below the .618 looking at 3.27 to buy back in....Collapse baby Collapse

[starkd748]

Lmfao learn how to trade the daily is overbought....Better to see if 3s hold

[Wi]

Back to $5.80 tomorrow. $$$

[starkd748]

Toast 3.30s tomorrow

[starkd748]

Not a gift if 4.50 doesn't hold up...Got out Friday looking for a rentry if 4.50 holds if not I'll wait for high 2s

[Wi]

Get those gifts while you can. $$$

[Wi]

Time to move up. $$$

[Milo1]

That $12 price target was before the patent awards, and FDA submission. Look for that target to be raised very soon.

[TopPick]

Theres a 12 dollar pt on wallstreet

[Wi]

Time to move up. $$$$

[Wi]

Hold what you have. It is simply only the beginning. $$$$